TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.6443
-0.0337 (-4.97%)
At close: Aug 14, 2026, 4:00 PM EDT
0.6650
+0.0207 (3.21%)
After-hours: Aug 14, 2026, 7:32 PM EDT

TELA Bio Revenue

TELA Bio had revenue of $19.29M in the quarter ending June 30, 2026, a decrease of -4.49%. This brings the company's revenue in the last twelve months to $79.91M, up 6.09% year-over-year. In the year 2025, TELA Bio had annual revenue of $80.28M with 15.84% growth.

Revenue (ttm)
$79.91M
Revenue Growth
+6.09%
P/S Ratio
0.36
Revenue / Employee
$366,550
Employees
218
Market Cap
28.84M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202580.28M10.98M15.84%
Dec 31, 202469.30M10.85M18.56%
Dec 31, 202358.45M17.04M41.13%
Dec 31, 202241.42M11.96M40.58%
Dec 31, 202129.46M11.25M61.77%
Dec 31, 202018.21M2.77M17.91%
Dec 31, 201915.45M7.17M86.68%
Dec 31, 20188.27M4.03M94.91%
Dec 31, 20174.25M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Accuray428.57M
Nortech Systems124.65M
Cytosorbents37.22M
QT Imaging Holdings26.43M
Baird Medical Investment Holdings22.54M
Lifeward20.92M
Pulsenmore12.55M
Elutia12.46M
Revenue Rankings